| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 1662 |
| 1 | PEMBROLIZUMAB | 1599 |
| 2 | NIVOLUMAB | 1395 |
| 3 | HYDROCORTISONE | 1119 |
| 4 | HYDROCORTISONE ACETATE | 966 |
| 5 | IPILIMUMAB | 937 |
| 6 | METHOTREXATE SODIUM | 924 |
| 7 | HYDROCORTISONE CREAM | 921 |
| 8 | ANTI-ITCH | 919 |
| 9 | ANTI-ITCH CREAM | 919 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRIAMCINOLONE HEXACETONIDE | 142 | 0.5420 |
| 1 | MITOTANE | 132 | 0.0741 |
| 2 | OSILODROSTAT | 135 | 0.0648 |
| 3 | COSYNTROPIN | 10 | 0.0461 |
| 4 | METYRAPONE | 43 | 0.0440 |
| 5 | HYDROCORTISONE VALERATE | 25 | 0.0411 |
| 6 | ANAKINRA | 527 | 0.0320 |
| 7 | PASIREOTIDE | 50 | 0.0224 |
| 8 | TREMELIMUMAB | 93 | 0.0221 |
| 9 | IPILIMUMAB | 937 | 0.0218 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 3996 |
| 1 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 3442 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1392 |
| 3 | CTLA-4-directed Blocking Antibody [EPC] | 1025 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 962 |
| 5 | Tumor Necrosis Factor Blocker [EPC] | 916 |
| 6 | Platinum-based Drug [EPC] | 871 |
| 7 | Kinase Inhibitor [EPC] | 833 |
| 8 | Proton Pump Inhibitor [EPC] | 750 |
| 9 | Vitamin C [EPC] | 636 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Adrenal Steroid Synthesis Inhibitor [EPC] | 43 | 0.0440 |
| 1 | Interleukin-1 Receptor Antagonist [EPC] | 527 | 0.0320 |
| 2 | Serotonin-4 Receptor Agonist [EPC] | 15 | 0.0243 |
| 3 | CTLA-4-directed Blocking Antibody [EPC] | 1025 | 0.0218 |
| 4 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 3442 | 0.0143 |
| 5 | Cyclooxygenase Inhibitor [EPC] | 1 | 0.0122 |
| 6 | Melanocortin 4 Receptor Agonist [EPC] | 3 | 0.0111 |
| 7 | Human Immunoglobulin G [EPC] | 230 | 0.0110 |
| 8 | Programmed Death Ligand-1 Blocker [EPC] | 232 | 0.0096 |
| 9 | Lymphocyte Activation Gene-3 Blocker [EPC] | 4 | 0.0085 |